Published by Michele Maatouk on 16th June 2023
(Sharecast News) - GSK said on Friday that the US Food and Drug Administration has extended the review period of its new drug application for momelotinib, which is used to treat a blood cancer called myelofibrosis.
URL: http://www.digitallook.com/dl/news/story/33577925/...